Enanta Pharmaceuticals, Inc. (ENTA) Covered Calls
Enanta Pharmaceuticals Inc is a research and development focused biotechnology company. It uses its robust chemistry-driven approach and drug discovery capabilities to create small molecule drugs in the infectious disease field.
You can sell covered calls on Enanta Pharmaceuticals, Inc. to lower risk and earn monthly income. Born To Sell's covered call screener gives you customized search capabilities across all possible covered calls but here are a couple of examples for ENTA (prices last updated Tue 4:16 PM ET):
| Enanta Pharmaceuticals, Inc. (ENTA) Stock Quote | ||||||
|---|---|---|---|---|---|---|
| Last | Change | Bid | Ask | Volume | P/E | Market Cap |
| 7.67 | -0.06 | 6.50 | 8.20 | 267K | - | 0.2 |
| Covered Calls For Enanta Pharmaceuticals, Inc. (ENTA) | ||||||
|---|---|---|---|---|---|---|
| Expiration | Strike | Call Bid | Net Debit | Return If Flat |
Annualized Return If Flat |
|
| Aug 15 | 7.5 | 0.00 | 8.20 | -8.5% | -124.1% | |
| Sep 19 | 7.5 | 0.00 | 8.20 | -8.5% | -51.7% | |
| Subscribers get access to the full covered call chain, and more features. | ||||||
Want to make money with covered calls? Sign Up For A Free Trial
Extended Business Description
Enanta Pharmaceuticals, Inc. is a research and development-focused biotechnology company, which uses its robust chemistry-driven approach and drug discovery capabilities to create small molecule drugs in the infectious disease field. It is discovering, and in some cases developing, novel inhibitors designed for use against the hepatitis C virus. These inhibitors include members of the direct acting antiviral inhibitor classes - protease, NS5A and nucleotide polymerase - as well as a host-targeted antiviral inhibitor class targeted against cyclophilin. Additionally, the company has created a new class of antibiotics, called Bicyclolides, for the treatment of multi-drug resistant bacteria, with a focus on developing an intravenous and oral treatment for hospital and community methicillin-resistant Staphylococcus aureus infections. Enanta Pharmaceuticals was founded by Peter O. Kliem and Gregory L. Verdine in 1995 and is headquartered in Watertown, MA.
| Top 10 Open Interest For Aug 15 Expiration | Top 5 High Yield | |||||
|---|---|---|---|---|---|---|
| 1. | SLV covered calls | 6. | IBIT covered calls | 1. | MBX covered calls | |
| 2. | NVDA covered calls | 7. | TSLA covered calls | 2. | EOSE covered calls | |
| 3. | GLD covered calls | 8. | AMZN covered calls | 3. | DNUT covered calls | |
| 4. | IWM covered calls | 9. | AAPL covered calls | 4. | RDDT covered calls | |
| 5. | SPY covered calls | 10. | QQQ covered calls | 5. | ENPH covered calls | |
Want more examples? ENSG Covered Calls | ENTG Covered Calls
